ICCMg 2024: The Power of mNGS for Infectious Disease Diagnosis

Traditional diagnostic methods have limited sensitivity, particularly after antimicrobial treatment or when dealing with fastidious organisms. While PCR improves detection, it is restricted to specific targets. 

Join us to see new data demonstrating the potential of Metagenomic Next-Generation Sequencing (mNGS) for pathogen identification in sterile body fluids. Learn about a study from the Tel-Aviv Sourasky Medical Center evaluates mNGS as a broader approach to pathogen detection.

Study Highlights:

92.1%

sensitivity in identifying
a range of pathogens

100%

specificity confirmed
in negative samples

Going to ICCMg?  

Meet us and Dr. Adler there.

If you are not attending the ICCMg conference in Geneva, watch our 30-minute Micro-Webinar to hear about the research.

Dr. Adler’s work focused on challenging sample types, using the Micronbrane Medical PaRTI-Seq assay, which includes the Devin Microbial Enrichment Kit and the Unison Ultralow DNA NGS Library Prep Kit. He will present data comparing traditional diagnostic methods with various mNGS approaches.